Leif Bjermer
11 – 20 of 374
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
- Contribution to journal › Article
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
- Contribution to journal › Article
-
Mark
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults
- Contribution to journal › Article
-
Mark
Disease burden and unmet need for acute allergic reactions – A patient perspective
- Contribution to journal › Article
-
Mark
The challenges of recruiting never-smokers with chronic obstructive pulmonary disease from the large population-based Swedish CArdiopulmonary bioImage study (SCAPIS) cohort
- Contribution to journal › Article
-
Mark
Expiratory and inspiratory resistance and reactance from respiratory oscillometry defining expiratory flow limitation in obstructive lung diseases
- Contribution to journal › Article
-
Mark
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
- Contribution to journal › Article
-
Mark
EUFOREUM Berlin 2023 : Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
- Contribution to journal › Article
-
Mark
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP
- Contribution to journal › Article
-
Mark
Expression of Stress-Induced Genes in Bronchoalveolar Lavage Cells and Lung Fibroblasts from Healthy and COPD Subjects
- Contribution to journal › Article
